1. 1,25D3 differentially suppresses bladder cancer cell migration and invasion through the induction of miR-101-3p
    Yingyu Ma et al, 2017, Oncotarget CrossRef
  2. lncRNA TINCR facilities bladder cancer progression via regulating miR‑7 and mTOR
    Guoying Xu et al, 2020, Molecular Medicine Reports CrossRef
  3. KPNA2 interaction with CBX8 contributes to the development and progression of bladder cancer by mediating the PRDM1/c-FOS pathway
    Fanchang Zeng et al, 2021, Journal of Translational Medicine CrossRef
  4. PBX1 Participates in Estrogen-mediated Bladder Cancer Progression and Chemo-resistance Affecting Estrogen Receptors
    Yinxu Wan et al, 2022, Current Cancer Drug Targets CrossRef
  5. NEAT1 promotes the malignant development of bladder cancer by regulating the miR-101/VEGF-C pathway in vitro and in vivo
    Huihui Zhang et al, 2022, BMC Urology CrossRef
  6. Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis
    Chunyu Zhang et al, 2021, Frontiers in Oncology CrossRef
  7. Cervical cancer stem cells manifest radioresistance: Association with upregulated AP-1 activity
    Abhishek Tyagi et al, 2017, Scientific Reports CrossRef
  8. Correlation of hsa miR-101-5p and hsa miR-155-3p Expression With c-Fos in Patients of Oral Submucous Fibrosis (OSMF) and Oral Squamous Cell Carcinoma (OSCC)
    Ankita Chugh et al, 2023, Journal of Maxillofacial and Oral Surgery CrossRef
  9. Non-coding RNAs in Various Stages of Liver Disease Leading to Hepatocellular Carcinoma: Differential Expression of miRNAs, piRNAs, lncRNAs, circRNAs, and sno/mt-RNAs
    Srinivas V. Koduru et al, 2018, Scientific Reports CrossRef
  10. MicroRNA181c inhibits prostate cancer cell growth and invasion by targeting multiple ERK signaling pathway components
    Zhengzheng Su et al, 2018, The Prostate CrossRef
  11. MiR-101 acts as a novel bio-marker in the diagnosis of bladder carcinoma
    Xiaoyan Chen, 2019, Medicine CrossRef
  12. Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets
    Cecilia Pop-Bica et al, 2017, International Journal of Molecular Sciences CrossRef
  13. MiR-101 inhibits cell proliferation and invasion of pancreatic cancer through targeting STMN1
    Lin Zhu et al, 2018, Cancer Biomarkers CrossRef
  14. How microRNAs affect the PD-L1 and its synthetic pathway in cancer
    Gholamreza Rezaei Danbaran et al, 2020, International Immunopharmacology CrossRef
  15. MicroRNAs and target molecules in bladder cancer
    Payam Kheirmand Parizi et al, 2020, Medical Oncology CrossRef
  16. G-Clamp Heterocycle Modification Containing Interstrand Photo-Cross-Linker to Capture Intracellular MicroRNA Targets
    Weiguo Shen et al, 2024, Journal of the American Chemical Society CrossRef
  17. Hsa-microRNA-101-3p expression in human urinary bladder cancer: Correlation with tumor pathology
    Yasmine A. Issa et al, 2018, Gene Reports CrossRef
  18. Novel sericin-based hepatocyte serum-free medium and sericin’s effect on hepatocyte transcriptome
    Yun Huang et al, 2018, World Journal of Gastroenterology CrossRef
  19. miR-193b and miR-30c-1* inhibit, whereas miR-576-5p enhances melanoma cell invasion in vitro
    Theresa Kordaß et al, 2018, Oncotarget CrossRef
  20. MicroRNA‑101 inhibits cell migration and invasion in bladder cancer via targeting FZD4
    Lei Chen et al, 2018, Experimental and Therapeutic Medicine CrossRef
  21. High Expression of Long Noncoding RNA MALAT1 Indicates a Poor Prognosis and Promotes Clinical Progression and Metastasis in Bladder Cancer
    Chao Li et al, 2017, Clinical Genitourinary Cancer CrossRef
  22. MicroRNA-101 downregulation increases C-Fos expression and contributes to the pathogenesis of non-small cell lung cancer
    Hai-jiang Wang et al, 2017, Turkish Journal of Biochemistry CrossRef
  23. The Role of MicroRNA in the Metastatic Phenotype of Bladder Cancer
    Aaron Perecman et al, 2022, Urologic Cancers CrossRef